VIM and breast cancer: Immunostainings of lungs from opioid-treated mice bearing breast cancer xenografts further demonstrated that the observed metastases are highly positive for Vimentin, a further mesenchymal marker, and negative for cleaved Caspase-3 (Fig. 3B).